Objective
To understand patient experiences in their own words, including the benefits and challenges of using ruxolitinib cream.
Introductions
Vitiligo is a chronic, autoimmune skin disease that results in patches of skin depigmentation.
MyVitiligoTeam members organically share their experiences living with and managing vitiligo with one another.
This study examines recent treatment conversations centered on using ruxolitinib cream (Opzelura®), providing helpful information on patients’ hopes, questions, and experiences with this new treatment option for vitiligo repigmentation.